Quality use of medicines within universal health coverage: challenges and opportunities - Wikidata - wikimedia - TriplyDB

Quality use of medicines within universal health coverage: challenges and opportunities

Quality use of medicines within universal health coverage: challenges and opportunities

http://www.wikidata.org/entity/Q34151454

about

Individual capacity-building approaches in a global pharmaceutical systems strengthening program: a selected review Defining pharmaceutical systems strengthening: concepts to enable measurement Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand.Medicines and universal health coverage: challenges and opportunities Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.A Review of Realizing the Universal Health Coverage (UHC) Goals by 2030: Part 1- Status quo, Requirements, and Challenges.Health insurance in India: what do we know and why is ethnographic research needed.How much could be saved in Chinese hospitals in procurement of anti-hypertensives and anti-diabetics?Estimates of Side Effects Counseling in Family Planning Using Three Data Sources: Implications for Monitoring and Survey Design.Investigating the impact of the universal healthcare coverage programme on community pharmacy practice.Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals.Rational prescribing of antibiotics in children under 5 years with upper respiratory tract infections in Kintampo Municipal Hospital in Brong Ahafo Region of Ghana.

P2860

Q29994765-3475AFBB-90CE-4BA0-8998-C01912173925 Q33589594-EE197295-FE30-424E-9F13-40AB16D26AA2 Q35128657-9F3FBDBA-9640-4CBC-A8AC-AB2EC5507B9E Q35149420-53BAF2B4-204E-46BE-8497-10296F3982A8 Q36089457-8823D6B0-7BA1-433A-83BD-C50C951166B5 Q38516530-9D3244BE-A346-42C4-8A08-A4B91CEF2F55 Q38717298-D3D71E7F-5B99-445D-964B-DA5F89216D3C Q39834356-A6CD49F2-579A-4036-B4E3-D5450DC1667B Q47189810-50F4FB5C-8743-4106-8A81-62311483BE80 Q48224278-064ED993-E8EE-443C-A701-D1D785D0E9BB Q50104677-2A38D8D0-75B1-4350-BEB0-838D39E61CAF Q55292839-1F890095-6A5C-44BB-978F-5B358C97B61D Q55669285-B40EA9E5-63E2-4662-9D32-36FF970F0E03

P2860

Quality use of medicines within universal health coverage: challenges and opportunities

http://www.wikidata.org/entity/Q34151454

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Quality use of medicines within universal health coverage: challenges and opportunities

@ast

Quality use of medicines within universal health coverage: challenges and opportunities

@en

Quality use of medicines within universal health coverage: challenges and opportunities

@nl

type

label

Quality use of medicines within universal health coverage: challenges and opportunities

@ast

Quality use of medicines within universal health coverage: challenges and opportunities

@en

Quality use of medicines within universal health coverage: challenges and opportunities

@nl

prefLabel

Quality use of medicines within universal health coverage: challenges and opportunities

@ast

Quality use of medicines within universal health coverage: challenges and opportunities

@en

Quality use of medicines within universal health coverage: challenges and opportunities

@nl

P1433

Q34151454-CBE2D5F3-A95A-4896-B8E7-6C8A2B2FF168

P1476

Q34151454-B4DF5F52-5B85-498E-819A-B904AABC840D

P2093

Q34151454-AAB80966-6CC4-41FE-BA87-80ECEA3849CF

P2860

Q34151454-142963F5-1894-4606-877D-89E0793636B3

Q34151454-5DB3E0EC-8F78-4C19-B14C-89E940BBC1C6

Q34151454-5F6949CD-0761-473C-B90E-8B6C2DDAD3B7

Q34151454-5FD5F361-0D6E-46D8-8ED2-54BA50175F9E

Q34151454-71B0E742-C4C2-4AA7-BFB7-7627C0D3F756

Q34151454-79ADC54F-ABE5-4962-BAD7-79F73B4BE3B8

Q34151454-7C81AF54-2451-442C-8504-B00A78286670

Q34151454-88FDD9D0-E1C3-46F1-88B1-66F2AB3C0FB3

Q34151454-A559DF1E-C8A7-4EB7-97BE-58BB0BC38052

Q34151454-CF99B874-DE41-4372-8F79-39933A77551D

P2888

Q34151454-1C591BD9-2E19-476B-B2D6-614C2F4C37F3

P304

Q34151454-09F3363D-17C3-4908-895B-502035F0B19A

P31

Q34151454-EFB5576D-A025-4922-B2FA-A766ECC0AD09

P356

Q34151454-D253127B-1D8A-4D71-9667-611AE90A1D64

P478

Q34151454-E0C6D164-0D67-4C17-A5F7-9476DEBDA64D

P50

Q34151454-185D14DA-3A99-4A91-A51E-68090143F2A7

Q34151454-97577792-088C-46F7-93D2-03C1BFEE73CC

P577

Q34151454-5338C61B-78E2-4D23-BE5C-F9E972155BD3

P5875

Q34151454-684A3831-324A-42F2-AB93-CC09791F25DA

P6179

Q34151454-C5AA2B3E-4AB5-4D28-8B27-4D921755FC5B

P698

Q34151454-3AE97F70-1B47-4DCF-A509-3B090AAA9054

P932

Q34151454-1A7BF1C0-95E9-485D-9D4A-6903BDBECE0C

P356

1472-6963-14-357

P1433

BMC Health Services Research

P1476

Quality use of medicines within universal health coverage: challenges and opportunities

@en

P2093

Anita K Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmaceutical policies: effects of cap and co-payment on rational drug use

Pharmaceutical policies: effects of financial incentives for prescribers

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007

Health insurance systems in five Sub-Saharan African countries: medicine benefits and data for decision making.

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

A systematic review of adherence to cardiovascular medications in resource-limited settings.

Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: a systematic review of current evidence.

P2888

1472-6963-14-357

P304

357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6963-14-357

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan D. Quick

Dennis Ross-Degnan

P577

2014-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265135314

http://www.w3.org/2001/XMLSchema#string

P6179

1047230318

http://www.w3.org/2001/XMLSchema#string

P698

25164588

http://www.w3.org/2001/XMLSchema#string

P932

4158132

http://www.w3.org/2001/XMLSchema#string